| Trial registration number
|
IRCT20200731048257N1 |
Full text link
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/50012
|
First author
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr. Reza Mohtashami
|
Contact
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
reza_mohtashami1979@yahoo.com
|
Registration date
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
2020-11-08
|
Recruitment status
Last imported at : March 5, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
multi-center
|
Study aim
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
informed consent to participate in the study
Patients 18 to 75 years of age with COVID-19 who have been diagnosed with PCR
Strong clinical suspicion of covid 19 with positive findings in CT Scan
Shortness of breath
|
Exclusion criteria
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Patients with HIV
Patients with cancer undergoing chemotherapy
Patients receiving Immune Mediators
Patients need hospitalization in the intensive care unit
Patients with uncontrolled heart, kidney or liver failure
Pregnant or lactating women
Intolerance to the drugs used in this study (symptoms such as diarrhea, nausea, vomiting and respiratory problems)
|
Number of arms
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Bagheiat-allah University of Medical Sciences
|
Inclusion age min
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
18
|
Inclusion age max
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
75
|
Countries
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
224
|
primary outcome
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dyspnea
|
Notes
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Nov. 9, 2020, midnight
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 985, "treatment_name": "Phr160", "treatment_type": "Others pharmacological treatment", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|